Grandpharma (00512) has completed domestic Phase III clinical trials of the global innovative ophthalmic drug GPN00833 and achieved clinical endpoints.
grandpharma (00512) announced that the group recently launched a steroid nano-suspension eye drop used for anti-inflammatory and analgesic purposes after eye surgery ...
Express News | iflytek co.,ltd.'s subsidiary alltronics technology company has been cancelled
Alltronics's Profit Plunges in H1 on Lower Sales Revenue
ALLTRONICS: Interim Report 2024
alltronics (00833.HK) potentially acquiring 51% of the electronic business in Vietnam for USD 2 million.
Alltronics (00833.HK) announced that it has signed a memorandum of understanding with the independent third party Rainno Holding PTE. The company intends to acquire a 51% indirect interest in Momentum Industrial (Vietnam), which has not yet begun operations, but plans to engage in electronic manufacturing in Vietnam. The consideration is 2 million US dollars.
Alltronics (00833.HK) plans to potentially acquire a 51% indirect stake in Momentum Industrial (Vietnam) for 2 million US dollars.
On September 11th, Groong Hui announced that on September 11, 2024, the company entered into a non-binding memorandum of understanding with Rainno Holding PTE Limited (Rainno), a company registered in the Republic of Singapore, regarding the potential acquisition of 51% indirect equity in Momentum Industrial (Vietnam) Limited (the target company), a limited company registered in Vietnam, for a proposed price of $2 million. The target company has not yet commenced operations.
ALLTRONICS To Go Ex-Dividend On September 20th, 2024 With 0.03 HKD Dividend Per Share
August 30th (Beijing Time) - $ALLTRONICS(00833.HK)$ is trading ex-dividend on September 20th, 2024.Shareholders of record on September 23rd, 2024 will receive 0.03 HKD dividend per share on October 24
Alltronics (00833) will distribute a mid-term dividend of HKD 0.03 per share on October 24th.
alltronics (00833) announced that it will distribute dividends as of June 30, 2024, on October 24, 2024...
Alltronics (00833.HK) mid-year operating income decreased by 27.7% to 0.5275 billion Hong Kong dollars
On August 29th, Alltronics (00833.HK) announced that for the six months ended on June 30, 2024, the company's total revenue decreased by 27.7% to HKD 527,500,000 from the same period of 2023, which was HKD 729,200,000. The decrease in revenue was due to a decrease in customer demand during the period. The attributable profit of the company's shareholders was HKD 36,100,000, compared to HKD 52,200,000 in the same period of 2023. The board of directors plans to declare an interim dividend of 3.0 HK cents per ordinary share.
ALLTRONICS: ANNOUNCEMENT OF UNAUDITED INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2024
Alltronics (00833.HK) plans to hold a board of directors meeting on August 29 to approve its mid-year performance.
Alltronics (00833.HK) announced that it will hold a board of directors meeting on Thursday, August 29, 2024, at Room 408, 4/F, Manulife Financial Centre, 18 Wai Yip Street, Hong Kong, to consider and approve the company's and its subsidiaries' mid-term results for the six months ending June 30, 2024, and propose the distribution of interim dividends (if applicable), as well as handle other matters.
ALLTRONICS: Annual Report 2023
ALLTRONICS To Go Ex-Dividend On June 7th, 2024 With 0.02 HKD Dividend Per Share
April 1st - $ALLTRONICS(00833.HK)$ is trading ex-dividend on June 7th, 2024. Shareholders of record on June 11th, 2024 will receive 0.02 HKD dividend per share on June 28th, 2024. The ex-dividend
Huaxun (00833) Announces Annual Results Profit attributable to shareholders of HK$108 million, a year-on-year decrease of 3.24%, and final interest of HK2 HK cents per share
According to the Zhitong Finance App, Huaxun (00833) announced the results for the year ended December 31, 2023. The Group's revenue was HK$1,347 million, a year-on-year decrease of 22.21%; profit attributable to shareholders was HK$108 million, a year-on-year decrease of 3.24%; profit per share was 22.92 HK cents; and final interest was HK$2 per share. According to the announcement, the decline in turnover was mainly due to a decrease in sales of electronic products.
ALLTRONICS: ANNOUNCEMENT OF FINAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2023
ECCOM (00833.HK) held a board meeting on March 28 to consider and approve the annual results
Glonghui March 14 | Huaxun (00833.HK) announced that it will hold a board meeting on March 28, 2024 (Thursday) to consider and approve the annual results of the company and its subsidiaries for the year ended 31 December 2023, the proposed final dividend (if applicable), and to deal with other matters.
Yuanda Pharmaceutical (00512): The new drug marketing application for the global innovative hormone nano-suspension eye drops GPN00833 was approved by the US FDA
Yuanda Pharmaceutical (00512) issued an announcement, and the group's partner in the field of ophthalmology, Taixin Pharmaceutical Co., Ltd. announced its use...
Alltronics Arm Reaches Settlement Deal With Dongguan Hongjun Packaging Products
Huaxun (00833): Shenzhen Dexun signed a settlement agreement with the plaintiff
Huaxun (00833) announced that Shenzhen Dexun has signed a settlement with the plaintiff on October 31, 2023...
Yuanda Pharmaceutical (00512) completed the phase III clinical trial of GPN00833, a hormone used for anti-inflammatory and analgesic analgesia, to enroll the first patient
Yuanda Pharmaceutical (00512) announced that the group's hormone nano suspension eye drops for anti-inflammatory and analgesic analgesia GPN0083...
No Data
No Data